CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention SPECT and PET in ischemic heart failure Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure

Original Research2006 Mar 23;354(12):1264-72.

JOURNAL:N Engl J Med. Article Link

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Cohen JC, Boerwinkle E, Mosley TH Jr et al. Keywords: PCSK9; Low LDL; CHD

FULL TEXT PDF